» Articles » PMID: 34360006

CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting

Overview
Journal Cells
Publisher MDPI
Date 2021 Aug 7
PMID 34360006
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The cluster of differentiation 36 (CD36) is a scavenger receptor present on various types of cells and has multiple biological functions that may be important in inflammation and in the pathogenesis of metabolic diseases, including diabetes. Here, we consider recent insights into how the CD36 response becomes deregulated under metabolic conditions, as well as the therapeutic benefits of CD36 inhibition, which may provide clues for developing strategies aimed at the treatment or prevention of diabetes associated with metabolic diseases. To facilitate this process further, it is important to pinpoint regulatory mechanisms that are relevant under physiological and pathological conditions. In particular, understanding the mechanisms involved in dictating specific CD36 downstream cellular outcomes will aid in the discovery of potent compounds that target specific CD36 downstream signaling cascades.

Citing Articles

Skin Microbiota: Mediator of Interactions Between Metabolic Disorders and Cutaneous Health and Disease.

Kreouzi M, Theodorakis N, Nikolaou M, Feretzakis G, Anastasiou A, Kalodanis K Microorganisms. 2025; 13(1).

PMID: 39858932 PMC: 11767725. DOI: 10.3390/microorganisms13010161.


Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System.

Park I, Chung Y, Won K Diabetes Metab J. 2025; 49(1):1-12.

PMID: 39828973 PMC: 11788556. DOI: 10.4093/dmj.2024.0796.


TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectives.

Sigalov A Front Immunol. 2024; 15:1498993.

PMID: 39737196 PMC: 11682994. DOI: 10.3389/fimmu.2024.1498993.


Ubiquitination and De-Ubiquitination in the Synthesis of Cow Milk Fat: Reality and Prospects.

Gao R, Wu Y, Wang Y, Yang Z, Mao Y, Yang Y Molecules. 2024; 29(17).

PMID: 39274941 PMC: 11397273. DOI: 10.3390/molecules29174093.


GPR40/GPR120 Agonist GW9508 Improves Metabolic Syndrome-Exacerbated Periodontitis in Mice.

Li Y, Yu H, Lopes-Virella M, Huang Y Int J Mol Sci. 2024; 25(17).

PMID: 39273569 PMC: 11394899. DOI: 10.3390/ijms25179622.


References
1.
Hani H, Allaudin Z, Mohd-Lila M, Sarsaifi K, Rasouli M, Tam Y . Improvement of isolated caprine islet survival and functionality in vitro by enhancing of PDX1 gene expression. Xenotransplantation. 2017; 24(3). DOI: 10.1111/xen.12302. View

2.
Moon J, Karunakaran U, Elumalai S, Lee I, Lee H, Kim Y . Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells. J Diabetes Complications. 2016; 31(1):21-30. DOI: 10.1016/j.jdiacomp.2016.09.001. View

3.
Jezek P, Holendova B, Jaburek M, Tauber J, Dlaskova A, Plecita-Hlavata L . The Pancreatic β-Cell: The Perfect Redox System. Antioxidants (Basel). 2021; 10(2). PMC: 7912581. DOI: 10.3390/antiox10020197. View

4.
Maedler K, Oberholzer J, Bucher P, Spinas G, Donath M . Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003; 52(3):726-33. DOI: 10.2337/diabetes.52.3.726. View

5.
Maedler K, Spinas G, Dyntar D, Moritz W, Kaiser N, Donath M . Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes. 2001; 50(1):69-76. DOI: 10.2337/diabetes.50.1.69. View